BlackRock Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCA
MIP
BFA
GIP
MERSOM
SIM
BlackRock Advisors's IRMD Position: Q4 2016 in Review
BlackRock Advisors held its iRadimed (IRMD) position steady in Q4 2016 at 1,212 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3534.
BlackRock Advisors first reported a position in IRMD in Q2 2015 and has held it in 7 quarters since. The position peaked at $237K in Q3 2015. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.
- BlackRock Advisors held 1,212 shares of iRadimed worth $13K as of Q4 2016.
- BlackRock Advisors left its iRadimed share count unchanged in Q4 2016.
- iRadimed made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3534 holding.
- BlackRock Advisors first reported a position in iRadimed in Q2 2015 and has held it in 7 quarters since.
- BlackRock Advisors's iRadimed position peaked at $237K in Q3 2015.
- 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.